Physician profile
Lev Pukin
NPI 1609849546
$3,248.90
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,538 · 2020: $1,251 · 2021: $40.99 · 2022: $97.41 · 2023: $321.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $321.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $321.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $1,714.44 | 2019-2020 | |
| Cardiovascular Systems INC. | $281.39 | 2019-2022 | |
| Medtronic Vascular, INC. | $255.96 | 2019 | |
| Boston Scientific Corporation | $208.42 | 2019-2023 | Idc |
| Abbott Laboratories | $186.97 | 2019-2020 | |
| Davol INC. | $174.57 | 2023 | Phasix Mesh |
| Angiodynamics, INC. | $158.91 | 2019-2021 | |
| Gilead Sciences, INC. | $82.83 | 2022 | |
| Terumo Medical Corporation | $51.11 | 2019 | |
| Biocompatibles, INC. | $49.68 | 2019 | |
| Cordis US Corp. | $35.52 | 2023 | Mynx Control |
| Bard Peripheral Vascular, INC. | $25.04 | 2021 | |
| Cardiva Medical, INC. | $24.06 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lev Pukin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.